Drug intelligence / Profile preview

retinal + niacinamide

Development stage
Unknown
Lead developer
Skin Medicinals
Modality
Small Molecules
Administration
Topical
01

Overview

Retinal + niacinamide is a topical combination therapy primarily utilized in dermatological and cosmetic applications for the treatment of photoaging, acne, and skin texture irregularities. **Retinal** (retinaldehyde) is a direct precursor to retinoic acid; upon topical application, it undergoes a single-step enzymatic conversion within keratinocytes to its active form, which subsequently binds to retinoic acid receptors (RARs) to modulate gene expression, promote cellular turnover, and stimulate collagen synthesis. **Niacinamide** (nicotinamide) is a water-soluble form of vitamin B3 that serves as a precursor to the coenzymes NAD+ and NADP+. In the skin, niacinamide functions as an anti-inflammatory agent, enhances the synthesis of barrier-forming lipids (such as ceramides), and inhibits the transfer of melanosomes from melanocytes to keratinocytes. The combination is strategically formulated to leverage the potent anti-aging effects of retinal while utilizing niacinamide to mitigate the localized irritation, erythema, and dryness typically associated with retinoid therapy.

Brand names
Youth to the People Retinal + Niacinamide Youth SerumNaturium Retinaldehyde Cream SerumMaelove Moonlight Retinal Super SerumGeek & Gorgeous A-Game
Other names
retinaldehyde + niacinamideretinaldehyde + nicotinamidevitamin A aldehyde + vitamin B3
02

Targets

PARP1 (Poly (adp-ribose) polymerase 1)RARA (Retinoic acid receptor alpha)RARB (Retinoic acid receptor beta)RARG (Retinoic acid receptor gamma)

Beyond the preview

Go deeper on retinal + niacinamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on retinal + niacinamide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call